Abstract
Biologic assays employed for screening novel peptides, once sequenced, or even during initial purification attempts, have evolved over the years from whole-animal models to isolated tissue systems in perfusion chambers, and, most recently, to systems employing cultured mammalian cells. The end product of these most recent bioassay systems can be monitored on the basis of cell growth or division, hormone secretion, or even changes in intracellular signaling events. It was using just such a bioassay that Matsuo et al. (1), in 1993, isolated a novel vasoactive hormone, termed adrenomedullin (AM). The peptide stimulated platelet adenylyl cyclase activity, and then, in whole-animal bioassay, was found to be a potent vasodilator (1). This chapter describes the identification of the pharmacologic and physiologic properties of AM and its sibling pair, proadrenomedullin N-terminal 20 peptide (PAMP), with particular focus on production in, and the effects on, the cardiovascular system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553–560.
Kitamura K, Sakata J, Kangawa K, Kojima H, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993; 194: 720–725.
Ishimitsu T, Kojima M, Hino J, Matsuoka H, Kitamura K, Eto T, Matsuo H. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994; 203: 631–639.
Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun 1993; 195: 921–927.
Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994; 338: 6–10.
Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, Sasano H, Mouri T. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and adrenal gland. Neurosci Lett 1996; 203: 207–210.
Washimine H, Asada Y, Kitamura K, Ichiki Y, Hara S, Yamamoto Y, et al Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue. Histochem Cell Biol 1995; 103: 251–254.
Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett 1994; 352: 105–108.
Ueta Y, Kitamura K, Isse T, Shibuya I, Kabashima N, Yamamoto S, et al. Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci Lett 1995; 202: 37–40.
Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160–1166.
Nishimori T, Tsujino M, Sato K, Imai T, Marumo F, Hirata Y. Dexamethasone-induced up-regulation of adrenomedullin and atrial natriuretic peptide genes in cultured rat ventricular myocytes. J Mol Cell Cardiol 1997; 29: 2125–2130.
Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, et al. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension 1998; 31: 505–510.
Chun TH, Itoh H, Ogawa Y, Tamura N, Takaya K, Igaki T, et al. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension 1997; 29: 1296–1302.
Jougasaki M, Wei CM, Mckinley II, Burnett JC. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995; 92: 286–289.
Minamino N, Shoji H, Sugo S, Kangawa K, Matsuo H. Adrenocortical steroids, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 211: 686–693.
Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, et al. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metab 1995; 80: 1750–1752.
Katoh F, Kitamura K, Niina H, Yamamoto R, Washimine H, Kangawa K, et al. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J Neurochem 1995; 64: 459–461.
Romppanen H, Marttila M, Magga J, Vuolteenaho O, Kinnunen P, Szokodi I, Ruskaoho H. Adrenomedullin gene expression in the rat heart is stimulated by acute pressure overload: blunted effect in experimental hypertension. Endocrinology 1997; 138: 2636–2639.
Samson WK. Cardiovascular hormones. In: Conn PM, Melmed S, eds. Endocrinology, Basic and Clinical Principles, Humana, Totowa, 1997, pp. 361–376.
Shimokubo T, Sakata J, Kitamura K, Kangawa K, Matsuo H, Eto T. Augmented adrenomedullin concentrations in right ventricle and plasma of experimental pulmonary hypertension. Life Sci 1995; 57: 1771–1779.
Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 207: 25–32.
Kitamura K, Ichiki Y, Tanaka M, Kawamoto M, Emura J, Sakakibara S, et al. Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994; 341: 288–290.
Sato K, Hirata Y, Imai T, Iwashina M, Marumo F. Characterization of immunoreactive adrenomedullin in human plasma and urine. Life Sci 1995; 57: 189–194.
Washimine H, Yamamoto Y, Kitamura K, Tanaka M, Ichiki Y, Kangawa K, Matsuo H, Eto T. Plasma concentrations of human adrenomedullin in patients on hemodialysis. Clin Nephrol 1995; 44: 389–393.
Meeran K, O’Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, Bloom SR. Circulating adrenomedullin does not regulate systemic BP but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 1997; 82: 95–100.
Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94: 2158–2161.
Kohno M, Hanehira T, Kano H, Horio T, Yokokawa K, Ikeda M, et al. Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996; 27: 102–107.
Cheung B, Leung R. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci 1997; 92: 59–62.
Taniyama M, Kitamura K, Ban Y, Sigita E, Ito K, Katagiri T. Elevation of circulating proadrenomedullin N-20 terminal peptide in thyrotoxicosis. Clin Endocrinol 1997; 46: 271–274.
Kohno M, Hanehira T, Hirata K, Kawaguchi T, Okishio K, Kano H, Kanazawa H, Yoshikawa J. Accelerated increase of plasma adrenomedullin in acute asthma. Metabolism 1996; 45: 1323–1325.
Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996; 81: 1449–1453.
Nishio K, Akai Y, Murao Y, Doi N, Ueda S, Tabuse H, et al. Increased plasma concentration of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 1997; 25: 953–957.
Shoji H, Minamino N, Kangawa K, Matsuo H. Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem Biophys Res Commun 1995; 215: 531–537.
Sugo S, Minamino N, Shoji H, Kangawa K, Matsuo H. Effects of vasoactive substance and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett 1995; 369: 311–314.
Kuchinke W, Hart RP, Jonakait GM. Identification of mRNAs regulated by interferon-gamma in cultured rat astrocytes by PCR differential display. Neuroimmunomodulation 1995; 2: 347–355.
Elhawary AM, Poon J, Pang CC. Effects of calcitonin gene related peptide antagonists on renal actions of adrenomedullin. Br J Pharmacol 1995; 115: 1133–1140.
Baskaya M, Suzuki Y, Anzai M, Seki Y, Saito K, Takayasu M, Shibuya M, Sigita K. Effects of adrenomedullin, calcitonin gene related peptide, and amylin on cerebral circulation in dogs. J Cereb Blood Flow Metab 1995; 15: 827–834.
Mori T, Takayasu M, Suzuki Y, Shibuya M, Yoshida J, Hidaka H. Effects of adrenomedullin on rat cerebral arterioles. Eur J Pharmacol 1997; 330: 195–198.
Berthiaume N, Claing A, Lippton H, Cadieux A, D’Orleans-Juste P. Rat adrenomedullin induces selective arterial vasodilation via CGRP1 receptors in the double perfused mesenteric bed of the rat. Can J Physiol Pharmacol 1995; 73: 1080–1083.
Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T, Wada A. Vasodilator effect of adrenomedullin and calcitonin gene related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 1993; 96: 245–251.
Lang MG, Paterno R, Faraci FM, Heistad DD. Mechanisms of adrenomedullin induced dilatation of cerebral arterioles. Stroke 1997; 28: 181–185.
Gardiner SM, Kemp PA, March JE, Bennett T. Regional hemodynamic effects of human and rat adrenomedullin in conscious rats. Br J Pharmacol 1995; 114: 584–591.
Haynes JM, Cooper ME. Adrenomedullin and calcitonin gene related peptide in the rat isolated kidney and the anesthetized rat: in vitro and in vivo effects. Eur J Pharmacol 1995; 280: 91–94.
Hjelmqvist H, Keil R, Mathai M, Hubschle T, Gertsberger R. Vasodilation and glomerular binding of adrenomedullin in rabbit kidney are not CGRP receptor mediated. Am J Physiol 1997; 273: R716 - R724.
Aiyar, H, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y. cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 1996;271:11, 325–11, 329.
Owji AA, Smith DM, Coppock HA, Morgan DGA, Bhogal R, Ghatei MA, Bloom SR. Abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 1995; 136: 2127–2134.
Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamura K, Eto T, Matsuo H. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation, and calcium mobilization, in bovine aortic endothelial cells. J Biol Chem 1995; 270: 4412–4417.
Samson WK, Murphy TC, Schell DA. Novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology 1995; 136: 2349–2352.
Sabates BL, Pigott JD, Choe EU, Cruz MP, Lippton HL, Hyman AL, Flint LM, Ferrara JJ. Adrenomedullin mediates coronary vasodilation through adenosine receptors and KATP channels. J Surg Res 1997; 67: 163–168.
Iwasaki H, Hirata Y, Iwashina M, Sato K, Marumo F. Specific binding for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat. Endocrinology 1996; 137: 3045–3050.
Feng CJ, Kang B, Kaye AD, Kadowitz PJ, Nossman BD. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sci 1994; 55: 433–438.
Shimosawa T, Ito Y, Ando K, Kitamura K, Kangawa K, Fujita T. Proadrenomedullin NH2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest 1995; 96: 1672–1676.
Takano K, Yamashita N, Fujita T. Proadrenomedullin N-terminal 20 peptide inhibits the voltage-gated calcium channel current through a pertussis toxin-sensitive G protein in rat pheochromocytomaderived PC12 cells. J Clin Invest 1996; 98: 14–17.
Lainchbury JG, Cooper GJ, Coy DH, Jiang NY, Lewis LK, Yandle TG, Richards AM, Nicholls MG. Adrenomedullin: a hypotensive hormone in man. Clin Sci 1997; 92: 467–472.
Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 1997; 95: 1214–1221.
Fukuhara M, Tsuchihashi T, Abe I, Fujishima M. Cardiovascular and neurohumoral effects of intravenous adrenomedullin in conscious rabbits. Am J Physiol 1995; 269: R1289 - R1293.
Kohno M, Yasunari Y, Yokokawa K, Horio T, Ikeda M, Minami M, Hanehira T, Yoshikawa J. Interaction of adrenomedullin and platelet derived growth factor on the production of endothelin. Hypertension 1996; 27: 663–667.
Nakamura K, Toda H, Terasako K, Nakuyama M, Hatano Y, Mori K, Kangawa K. Vasodilative effect of adrenomedullin in isolated arteries of the dog. Jpn J Pharmacol 1995; 67: 259–262.
Kato J, Kitamura K, Kangawa K, Eto T. Receptors for adrenomedullin in human vascular endothelial cells. Eur J Pharmacol 1995; 289: 383–385.
Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe TX, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994; 340: 226–230.
Kureshi Y, Kobayashi S, Nishimura J, Nakano T, Kanaide H. Adrenomedullin decreases both cytosolic calcium concentration and calcium sensitivity in pig coronary arterial smooth muscle. Biochem Biophys Res Commun 1995; 212: 572–579.
Kano H, Kohno M, Yasunari K, Yokokawa K, Horio T, Ikeda M, et al. Adrenomedullin as a novel antiproliferative factor in vascular smooth muscle cells. J Hypertension 1996; 14: 209–213.
Kohno M, Yokokawa K, Kano H, Yasunari K, Minami M, Hanehira T, Yoshikawa J. Adrenomedullin is a potent inhibitor of angiotensin II induced migration of human coronary artery smooth muscle cells. Hypertension 1997; 29: 1309–1313.
Chini EN, Choi E, Grande JP, Burnett JC, Douse TP. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem Biophys Res Commun 1995; 215: 868–873.
Kato H, Shichiri M, Marumo F, Hirata Y. Adrenomedullin as an autocrine/paracrine survival factor for rat endothelial cells. Endocrinology 1997; 138: 2615–2620.
Ebara T, Mura K, Okumura M, Matsuura T, Kim S, Yukimura T, Iwao H. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol 1994; 263: 69–73.
Jougasaki M, Wei CM, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol 1995; 268: F657 - F663.
Hirata Y, Hayakawa H, Suzuki Y, Suzuki Y, Ikenouchi H, Kohmoto O, et al. Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 1995; 25: 790–795.
Owada A, Nonoguchi H, Terada Y, Marumo F, Tomita K. Microlocalization and effects of adrenomedullin in nephron segments and in mesangial cells of the rat. Am J Physiol 1997; 272: F691 - F697.
Yokoi H, Arima T, Kondo K, Iwasaki Y, Oiso Y. Intracerebroventricular injection of adrenomedullin inhibits vasopressin release in conscious rats. Neurosci Lett 1996; 216: 65–67.
Andreis PG, Neri G, Prayer-Galetti T, Rossi GP, Gottardo G, Malendowicz LK, Nussdorfer GG. Effects of adrenomedullin on the human adrenal glands: an in vitro study. J Clin Endocrinol Metab 1997; 82: 1167–1170.
Yamaguchi T, Baba K, Doi Y, Yano K. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci 1995; 56: 379–387.
Jougasaki M, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC. Role of prostaglandins and renal nerves in the renal actions of adrenomedullin. Am J Physiol 1997; 272: F260 - F266.
Segawa K, Minami K, Sata T, Kuroiwa A, Shigematsu A. Inhibitory effect of adrenomedullin on rat mesangial cell mitogenesis. Nephron 1996; 74: 577–579.
Edwards RM, Trizna W, Stack E, Aiyar N. Effect of adrenomedullin on cAMP levels along the rat nephron: comparison with CGRP Am J Physiol 1996; 271: F895 - F899.
Jensen BL, Kramer BK, Kurtz A. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells. Hypertension 1997; 29: 1148–1155.
Andreis PG, Mazzocchi G, Rebuffat P, Nussdorfer GG. Effects of adrenomedullin and proadrenomedullin N-terminal 20 peptide on rat zona glomerulosa cells. Life Sci 1997; 60: 1693–1697.
Parkes DG, May CN. 1995; ACTH-suppressive and vasodilator actions of AM in conscious sheep. J Neuroendocrinology 7: 923–929.
Grantham JA, Burnett JC. Natriuretic peptides in cardiovascular disease. In: Samson WK, Levin ER, eds. Contemporary Endocrinology, Natriuretic Peptides in Health and Disease Humana, Totowa, 1997, pp. 309–326.
Sumimoto T, Nishikimi T, Mukai M, Matsuzaki K, Murakami E, Takishita S, Miyata A, Matsuo H, Kangawa K. Plasma adrenomedullin concetrations and cardiac and arterial hypertrophy in hypertension. Hypertension 1997; 30: 741–745.
Inatsu H, Sakata J, Shimokubo T, Kitani M, Nishizoni M, Washimine H, et al. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat. Biochem Mol Biol Int 1996; 38: 365–372.
Sato A, Autelitano DJ. Adrenomedullin induces expression of c-fos and AP-1 activity in rat vascular smooth muscle cells and cardiomyocytes. Biochem Biophys Res Commun 1995; 217: 211–216.
Sato A, Canny BJ, Autelitano DJ. Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocyte. Biochem Biophys Res Commun 1997; 230: 311–314.
Szokodi I„ Kinnunen P„ Ruskoaho H. Inotropic effect of AM in the isolated perfused rat heart. Acta Physiol Scand 1996; 156: 151–152.
Parkes DG. Cardiovascular actions of adrenomedullin in conscious sheep. Am J Physiol 1995; 268: H2574 - H2578.
Charles CJ, Rademaker MT, Richards AM, Cooper CJ, Coy DH, Jing NY, Nicholls MG. Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep. Am J Physiol 1997; 272: R2040 - R2047.
Parkes DG, May CN. Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol 1997; 120: 1179–1185.
Rademaker MT, Charles CJ, Lewis LK, Yandle TG, Cooper GJ, Coy DH, Richards AM, Nicholls MG. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 1997; 96: 1983–1990.
DeWitt BJ, Cheng DY, Caminiti GN, Nossaman BD, Coy DH, Murphy WA, Kadowitz PA. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in pulmonary vascular bed of the cat. Eur J Pharmacol 1994; 257: 303–306.
Shirai M, Shimouchi A, Ikeda S, Ninomiya I, Sunagawa K, Kangawa K, Matsuo H. Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anesthetized cats. Br J Pharmacol 1997; 121: 679–686.
Yang BC, Lippton H, Gumusel B, Hyman A, Mehta JL. Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins, J Cardiovasc Pharmacol 1997; 28: 458–462.
Yoshibayashi M, Kamiya T, Kitamura K, Saito Y, Kangawa K, Nishikimi T, et al. Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients *20 years of age. Am J Cardiol 1997; 79: 1558–1558.
deVroomen M, Takahashi Y, Gournay V, Roman C, Rudolph AM, Heyman MA. Adrenomedullin increases pulmonary blood flow in fetal sheep. Pediatr Res 1997; 41: 493–497.
Kamoi H, Kanazawa K, Hirata K, Kurihara N, Yano Y, Otani S. Adrenomedullin inhibits the secretion of cytokine induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem Biophys Res Commun 1995; 211: 1031–1035.
Allen MA, Ferguson AV. In vitro recordings from area postrema neurons demonstrate responsiveness to adrenomedullin. Am J Physiol 1996; 270: R920 - R925.
Yeung VT, Ho SK, Nicholls MG, Cockram CS. Adrenomedullin, a novel vasoactive hormone, binds to mouse astrocytes and stimulates cyclic AMP production. J Neurosci Res 1996; 46: 330–335.
Dogan A, Suzuki Y, Koketsu N, Osuka K, Saito K, Takayasu M, Shibuya M, Yoshida J. Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1997; 17: 19–25.
Zimmerman U, Fischer JA, Frei K, Fischer AH, Reinscheid RK, Muff R. Identification of adrenomedullin receptors in cultured rat astrocytes and in neuroblastoma x glioma hybrid cells (NG 108–15). Brain Res 1996; 724: 238–245.
Levin ER. Natriuretic peptide C-receptor: more than a clearance receptor. Am J Physiol 1993; 264: E484 - E489.
Murphy TC, Samson WK. Novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat. Endocrinology 1995; 136: 2459–2463.
Samson WK, Murphy TC. Adrenomedullin inhibits salt appetite. Endocrinology 1996; 138: 613–616.
Krahn DD, Gosnell BA, Levine AS, Morley JE. Effects of calcitonin gene related peptide on food intake. Peptides 1984; 5: 861–864.
Taylor GM, Meeran K, O’Shea D, Smith DM, Ghatei MA, Bloom SR. Adrenomedullin inhibits feeding in the rat by a mechanism involving calcitonin gene related peptide receptors. Endocrinology 1996; 137: 3260–3264.
Samson WK, Murphy TC, Resch ZT. Central mechanisms for the hypertensive effects of preproAM derived peptides in conscious rats. Am J Physiol 1998; 274: R1505 — R1510.
Blackburn RE, Samson WK, Fulton RJ, Stricker EM, Verbalis JG. Central oxytocin inhibition of salt appetite in rats: evidence for differential sensing of plasma sodium and osmolality. Proc Natl Acad Sci USA 1993;90:10, 380–10, 384.
Blackburn RE, Samson WK, Fulton RJ, Stricker EM, Verbalis JG. Central oxytocin and ANP receptors mediate osmotic inhibition of salt appetite in rats. Am J Physiol 1995; 269: R245 - R251.
Martinez V, Cuttitta F, Tache Y. Central action of adrenomedullin to inhibit gastric emptying in rats. Endocrinology 1997; 138: 3749–3755.
Takahashi H, Watanabe T, Nishimura M, Nakanishi T, Sakamoto M, Yoshimura M, et al. Centrally induced vasopressor and sympathetic responses to a novel endogenous peptide, adrenomedullin, in anesthetized rats. Am J Hypertension 1994; 7: 478–482.
Allen MA, Smith PA, Ferguson AV. Adrenomedullin microinjection into the area postrema increases blood pressure. Am J Physiol 1997; 272: R1698–1703.
Samson WK, Murphy TC, Resch ZT. Proadrenomedullin N-20 terminal peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel. Endocrine 1998; 9: 269–272.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Samson, W.K. (1999). Adrenomedullin and the Heart. In: Share, L. (eds) Hormones and the Heart in Health and Disease. Contemporary Endocrinology, vol 21. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-708-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-708-6_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5420-9
Online ISBN: 978-1-59259-708-6
eBook Packages: Springer Book Archive